Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
Pulse Biosciences, Inc (PLSE)
Last pulse biosciences, inc earnings: 11/7 03:42 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.pulsebiosciences.com
Company Research
Source: Business Wire
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the upcoming presentation of early clinical data on the treatment of atrial fibrillation (AF) using the nPulse™ Cardiac Surgical System at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting from October 8-11th in Copenhagen, Denmark.“The FDA’s recent approval of our IDE study for the nPulse™ Cardiac Surgical System marks a significant milestone in the development of our novel technology for the treatment of atrial fibrillation," said Paul LaViolette, Co-Chairman and CEO of Pulse Biosciences. “We are excited for the early clinical evidence supporting the safety and efficacy of nPulse™ to be featured at the world’s largest cardiothoracic surgery meeting and we appreciate the dedication of the clinicians continuing to evaluate and util
Show less
Read more
Impact Snapshot
Event Time:
PLSE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PLSE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PLSE alerts
High impacting Pulse Biosciences, Inc news events
Weekly update
A roundup of the hottest topics
PLSE
News
- Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Pulse Biosciences, Inc. Announces Participation in Upcoming Investor ConferencesBusiness Wire
- Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences, Inc. (PLSE) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial ResultsBusiness Wire
PLSE
Earnings
- 11/5/25 - Beat
PLSE
Sec Filings
- 11/13/25 - Form 8-K
- 11/5/25 - Form 10-Q
- 11/5/25 - Form 8-K
- PLSE's page on the SEC website